Particle composition and pharmaceutical composition using particle composition
US9278075B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Jan 16, 2012 |
| Grant date | Mar 8, 2016 |
| Priority date | — |
| Expiry date | Aug 7, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition of matter for use in encapsulating a drug is expressed by formula (1) or formula (2):wherein R1 and R2 are each independently a hydrogen atom or a substituted or unsubstituted, linear or branched alkyl group having 1 to 12 carbon atoms; A is a hydrophilic polymer chain; L1 and L3 are each a linking group; B is a cation-containing group; R3 is a side chain of an amino acid; z is an integer of 5 to 500; x is an integer of 40% or more of z; y is 0 or a positive integer; z-x-y is 0 or a positive integer; p is an integer of 1 to 10; and q is an integer of 1 to 10.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.